Prognostic and clinicopathological value of NM23 expression in patients with breast cancer: A systematic review and meta-analysis
Authors:
- 1 January 2017
- journal article
- review article
- Published by Elsevier in Current Problems in Cancer
- Vol. 41 (1) , 80-93
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- High incidence of microsatellite instability and loss of heterozygosity in three loci in breast cancer patients receiving chemotherapy: a prospective studyBMC Cancer, 2012
- A Logistic Regression Model for Predicting Axillary Lymph Node Metastases in Early Breast Carcinoma PatientsSensors, 2012
- Regulation of Nm23-H1 and Cell Invasiveness by Kaposi's Sarcoma-Associated HerpesvirusJournal of Virology, 2011
- Implication of Metastasis Suppressor NM23-H1 in Maintaining Adherens Junctions and Limiting the Invasive Potential of Human Cancer CellsCancer Research, 2010
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- The Nm23-H1 metastasis suppressor as a translational targetEuropean Journal of Cancer, 2010
- Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behavioursEmerging Themes in Epidemiology, 2008
- Expression of nm23 in gastric carcinomaCancer, 1998
- Analysis of Oncogenes and Tumor Suppressor Genes in Human Breast CancerJapanese Journal of Cancer Research, 1993